Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin (Q40666421)

22 September 2017

title

Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin (English)

1 reference

22 September 2017

Jih I Chuang

1

1 reference

22 September 2017

Tsuey Y Chang

series ordinal

2

1 reference

22 September 2017

Hsiao S Liu

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

22

1 reference

22 September 2017

issue

9

1 reference

22 September 2017

page(s)

1349-1357

1 reference

Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Protective effect of melatonin against adriamycin toxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Relationship between colorectal cancer glutathione levels and patient survival: early results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Selective activation of Ha-ras(val12) oncogene increases susceptibilityof NIH/3T3 cells to TNF-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

The antioxidant melatonin reduces cortical neuronal death after intrastriatal injection of kainate in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Alteration of Bcl-2 expression in the nigrostriatal system after kainate injection with or without melatonin co-treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Melatonin and mammary pathological growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Effects of melatonin on doxorubicin cytotoxicity in sensitive and pleiotropically resistant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

A Rac1 Effector Site Controlling Mitogenesis through Superoxide Production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Inhibition of cell proliferation: a mechanism likely to mediate the prevention of neuronal cell death by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

Mitochondrial dysfunction in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Biologic and pharmacologic regulation of mammalian glutathione synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Ras activation in astrocytomas and neurofibromas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Glutathione: new candidate neuropeptide in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Ras, superoxide and signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Microassay for studying anticellular effects of human interferons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Differential induction of apoptosis in oncogene-transformed NIH 3T3 cells by methylmethanesulfonate.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Posttranscriptional down-regulation of ras oncogene expression by inhibitors of cellular glutathione

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

A radical hypothesis for neurodegeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Melatonin has no effect on the growth, morphology or cell cycle of human breast cancer (MCF-7), cervical cancer (HeLa), osteosarcoma (MG-63) or lymphoblastoid (TK6) cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

The oncostatic action of melatonin in an ovarian carcinoma cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Melatonin protects the heart against both ischemia/reperfusion injury and chemotherapeutic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Melatonin suppression of PC12 cell growth and death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Differential effects of L-buthionine sulfoximine and ethacrynic acid on glutathione levels and mitochondrial function in PC12 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Induction of glutathione content in murine melanocytes after transformation with c-H-ras oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Development of resistance to glutathione depletion-induced cell death in CC531 colon carcinoma cells: association with increased expression of bcl-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

N-ras mRNA expression is unaffected in glutathione-depleted cells of hematopoietic origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Melatonin protects against cardiac toxicity of doxorubicin in rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206289

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206289

1 reference

Dimensions Publication ID

22 September 2017

1024787934

0 references

Fatcat ID

release_zsekvwflmjcsxcc2jhsogldowm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zsekvwflmjcsxcc2jhsogldowm

24 November 2022

mapped directly with Wikidata item

1 reference